SIA NeiroMedActive
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2013–2025
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||
| Total current assets | 670 | 1245 | 1083 | 927 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 032 |
| Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 386 423 |
| Total assets | 670 | 1245 | 1083 | 927 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 460 455 |
| Balance sheet — liabilities and equity | |||||||||||||
| Current liabilities | 0 | 0 | 0 | 0 | 50 | 100 | 150 | 200 | 250 | 300 | 380 | 431 | 137 251 |
| Non-current liabilities | 664 | 929 | 917 | 920 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 228 764 |
| Total liabilities | 664 | 929 | 917 | 920 | 50 | 100 | 150 | 200 | 250 | 300 | 380 | 431 | 366 015 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -4 | 308 | -150 | -158 | -57 | -50 | -50 | -50 | -50 | -50 | -80 | -51 | -55 115 |
| Total equity | 6 | 316 | 166 | 7 | -50 | -100 | -150 | -200 | -250 | -300 | -380 | -431 | 94 440 |
| Income statement | |||||||||||||
| Sales revenue | 4976 | 10 063 | 9645 | 9600 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65 160 |
| Operating profit | 444 | 1214 | 718 | -158 | -7 | 0 | 0 | 0 | 0 | 0 | -30 | -1 | -55 066 |
| Profit before income tax | 444 | 1214 | 718 | -158 | -7 | 0 | 0 | 0 | 0 | 0 | -30 | -1 | -55 066 |
| Profit for the reporting year | -4 | 308 | -150 | -158 | -57 | -50 | -50 | -50 | -50 | -50 | -80 | -51 | -55 115 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
- SIA KALNCIEMA NEIROKLĪNIKA — 3 shared people
- "L. Paegles 4a"
- "Latvijas Neiroķirurģijas attīstības biedrība"
- "RĪGAS AUSTRUMU KLĪNISKĀS UNIVERSITĀTES SLIMNĪCAS ATBALSTA FONDS"
- Latvijas Neirologu biedrība
- Latvijas Neiroķirurgu biedrība
- Latvijas Sāpju izpētes biedrība
- SIA "DIZZI"
- SIA "LA74"
- SIA "Rehab Baltics"
- Sabiedrība ar ierobežotu atbildību "D.A.P."
- Sabiedrība ar ierobežotu atbildību "DETOX"
Summary: SIA NeiroMed
Overview
SIA NeiroMed (reg. no. 40103649928) is a limited liability company. The company was registered in 2013 and has been in the register for 13 years. Registered address: Rīga, Gunāra Astras iela 8B.
Financial results
Revenue in 2025 was 65 160 €. From 2013 to 2025, revenue grew by an average of 23,9% per year. This is the company's highest revenue among the published years (2013–2025). 2025 ended with a loss of 55 115 €. The company was profitable in 1 of the 13 published years. In 2025 the company had 17 employees (0 a year earlier). Revenue per employee was 3833 €. At the end of 2025, total assets were 460 455 € and equity 94 440 € (20,5% of assets).
Management and owners
The board has 3 members. According to the register, the company has 7 owners. The largest stake (16%) is held by a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.